Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07571291
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSISFondazione IRCCS Policlinico San Matteo di PaviaActive Not Recruiting
NCT07571291Active Not Recruiting
—
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF I...Fondazione IRCCS Policlin...
NCT07570225
Innovative Non-Invasive Diagnostics and Personalized Treatment Strategies for Endometriosis Through Advanced Multi-Omics and Ultrasound IntegrationKarolinska InstitutetNot Yet Recruiting
NCT07570225Not Yet Recruiting
—
Innovative Non-Invasive Diagnostics and Personalized Treatment Strategies for En...Karolinska Institutet
NCT07570914
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesTianjin Medical University Cancer Institute and HospitalNot Yet RecruitingPhase 2
NCT07570914Not Yet Recruiting
Phase 2
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitab...Tianjin Medical Universit...
NCT07569354
Recovery Among Older Adults Following Mild TBINational Institute on Aging (NIA)Recruiting
NCT07569692
(PREventive Invasive Strategy for Obstructive Coronary Artery Disease With Vulnerable Plaque Evaluated by CoroNary Computed Tomography Angiography)-2CardioVascular Research Foundation, KoreaNot Yet RecruitingNot Applicable
NCT07569692Not Yet Recruiting
Not Applicable
(PREventive Invasive Strategy for Obstructive Coronary Artery Disease With Vulne...CardioVascular Research F...
NCT07569419
Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic FibrosisUniversity of NottinghamRecruitingEarly Phase 1
NCT07569419Recruiting
Early Phase 1
Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic Fibrosi...University of Nottingham
NCT07569367
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia SpectrumBioSensicsNot Yet Recruiting
NCT07569367Not Yet Recruiting
—
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotem...BioSensics
NCT07571707
Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing General AnesthesiaUdayana UniversityRecruitingNot Applicable
NCT07571707Recruiting
Not Applicable
Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing Genera...Udayana University
NCT07570836
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan HospitalNot Yet RecruitingPhase 1
NCT07570836Not Yet Recruiting
Phase 1
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan Hospit...
NCT07570511
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy, FranceNot Yet RecruitingNot Applicable
NCT07570511Not Yet Recruiting
Not Applicable
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy,...
NCT07570147
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult ParticipantsAbbVieNot Yet RecruitingPhase 1
NCT07570147Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Asc...AbbVie
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07569783
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Nantong UniversityNot Yet RecruitingNot Applicable
NCT07569783Not Yet Recruiting
Not Applicable
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Na...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570017
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaGuangzhou Lupeng Pharmaceutical Company LTD.Not Yet RecruitingPhase 1
NCT07570017Not Yet Recruiting
Phase 1
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refrac...Guangzhou Lupeng Pharmace...
NCT07568587
Myocardial Function Recovery Prediction Post Primary PCI Using the Estimate of Myocardial Salvage in Gated SPECT Early After Acute Myocardial InfarctionFayoum UniversityCompleted
NCT07568587Completed
—
Myocardial Function Recovery Prediction Post Primary PCI Using the Estimate of M...Fayoum University
NCT07571252
Impact of Preemptive Analgesia on Postoperative Pain in Orthognathic SurgeryUniversity of Puerto RicoNot Yet RecruitingPhase 4
NCT07571252Not Yet Recruiting
Phase 4
Impact of Preemptive Analgesia on Postoperative Pain in Orthognathic SurgeryUniversity of Puerto Rico
NCT07570667
Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promote Early-stage Disease Detection and Personalized/Precision Care Using Innovative Research PlatformsCenter for Molecular Fingerprinting Research Nonprofit LLCNot Yet Recruiting
NCT07570667Not Yet Recruiting
—
Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promo...Center for Molecular Fing...
NCT07571681
Colchicine for Autoimmune and Subacute ThyroiditisMansoura UniversityNot Yet RecruitingPhase 2
NCT07571681Not Yet Recruiting
Phase 2
Colchicine for Autoimmune and Subacute ThyroiditisMansoura University
NCT07568730
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep 4 μM Ophthalmic Solution in Subjects With Neurotrophic KeratitisTearSolutions, Inc.RecruitingPhase 2
NCT07568730Recruiting
Phase 2
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study...TearSolutions, Inc.
Result Breakdown
Not yet recruiting12 (60%)
Recruiting6 (30%)
Active, not recruiting1 (5%)
Completed1 (5%)
Not Specified6 (30%)
not_applicable5 (25%)
Phase 24 (20%)
Phase 13 (15%)
Early Phase 11 (5%)
Phase 41 (5%)